-Renal autoregulation is impaired in early (1 wk) diabetes mellitus (DM) induced by streptozotocin, but effective in established DM (4 wk). Furthermore nitric oxide synthesis (NOS) inhibition with N G -nitro-L-arginine methyl ester (L-NAME) significantly improved autoregulation in early DM but not in established DM. We hypothesized that autoregulation is transiently impaired in early DM because of increased NO availability in the kidney. Because of the conflicting evidence available for a role of NO in DM, we tested the hypothesis that DM reduces autoregulation effectiveness by reducing the spatial similarity of autoregulation. Male Long-Evans rats were divided into control (CON) and diabetic (DM; streptozotocin) groups and followed for either 1 wk (CON1, n ϭ 6; DM1, n ϭ 5) or 4 wk (CON4, n ϭ 7; DM4, n ϭ 7). At the end of the experiment, dynamic autoregulation was assessed in isoflurane-anesthetized rats by whole kidney RBF during baseline, NOS1 inhibition, and nonselective NOS inhibition. Kidney surface perfusion, monitored with laser speckle contrast imaging, was used to assess spatial heterogeneity of autoregulation. Autoregulation was significantly impaired in DM1 rats and not impaired in DM4 rats. L-NAME caused strong renal vasoconstriction in all rats, but did not significantly affect autoregulation dynamics. Autoregulation was more spatially heterogeneous in DM1, but not DM4. Therefore, our results, which are consistent with transient impairment of autoregulation in DM, argue against the hypothesis that this impairment is NO-dependent, and suggest that spatial properties of autoregulation may also contribute to reduced autoregulatory effectiveness in DM1. diabetes mellitus; laser speckle contrast imaging; nitric oxide; renal blood flow; synchronization DIABETES MELLITUS (DM) IS one of the most common causes of end-stage renal disease in North America (40a). A key pathological mechanism of kidney injury in DM is increased glomerular capillary pressure (69, 70), or glomerular hypertension, which eventually leads to glomerular structural damage and renal failure (32). Glomerular hypertension results from a reduction in afferent arteriolar vascular resistance, which manifests in diabetics as increased glomerular filtration rate, or hyperfiltration. Autoregulation of renal blood flow (RBF) is the only known mechanism that stabilizes glomerular filtration rate and RBF when blood pressure (BP) fluctuates (36) and is mediated by the myogenic response (MR) and tubuloglomerular feedback (TGF) (16, 40) . Therefore, impaired autoregulation in DM or preglomerular vasodilatation could lead to subsequent renal damage.
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Nitric oxide (NO) has been suggested as one cause of diabetic hyperfiltration (2, 11, 26, 31, 34, 49, 52, 62) . NO causes relaxation of preglomerular renal arterioles (67) and reduces the autoregulatory efficiency of both TGF (8, 28, 29, 59, 66) and the MR (25, 64) . NO is synthesized by NO synthase (NOS). Of the three NOS isoforms present in the kidney, NOS1 has been shown to modulate TGF signaling (10, 24, 48, 56, 61) , and NOS3-derived NO has been reported to impair the MR (17) . In DM, the control of TGF by NOS1 is reduced (54) , although NOS1 appears to substantially contribute to elevated glomerular filtration rate (31) .
Reports regarding RBF autoregulation are not consistent, showing that DM causes impaired (3, 4, 21, 60, 68) , normal (33, 42) , or even improved autoregulation (50, 57) . Particularly, we reported effective autoregulation in established DM (4 -13 wk) (33, 50) , while Bell et al. (5, 6) reported impaired autoregulation in early DM (1 wk). Therefore, impaired autoregulation in early DM seems transient, although this conclusion can only be tentative because this has not been tested directly.
Increased intrarenal NO in early DM is consistent with afferent arteriolar vasodilation and with impaired RBF autoregulation. Additionally, chronic inhibition of NOS prevented impaired autoregulation and increased RBF associated with early DM (5). NOS inhibition in established DM did not affect intact dynamic autoregulation, although it reduced RBF (33) . Because autoregulation was intact and NOS inhibition was acute instead of chronic, the role of NO in DM is unclear.
Previously, we, and others, reported large-scale synchronization of renal autoregulation dynamics in renal surface perfusion (9, 23, 39, 45) and suggested that it is mediated by communication among vascular branches via gap junctions (9, 39) . Furthermore, previous results suggest synchronized autoregulation dynamics contribute to the effectiveness of autoregulation (18, 58) . The expression of connexin proteins in the renal microvasculature has been reported to be altered in DM (71) , and reduced connexin-dependent communication may be involved in impaired autoregulation in DM (53) .
Because the roles of NO in DM are not fully clear, and the pathological effect of DM on the synchronization of autoregulation is unknown, we hypothesized that 1) autoregulation is impaired in early, but not established DM, 2) that this impairment is caused by increased NOS1-derived NO, and 3) that if NO is not responsible, then a reduction in network behavior of autoregulation may be involved in reducing the effectiveness of autoregulation in early DM.
METHODS

Animals.
Experiments were conducted in accordance with the guidelines of the Canadian Council on Animal Care and received prior approval from the Animal Care Committee of Simon Fraser University. Male Long-Evans rats (aged 12-16 wk) were purchased from Harlan Laboratories (Livermore, CA), housed in groups of 2-6 in a 12:12-h light-dark cycle, and provided with ad libitum access to standard rat chow (LabDiet 5001) and distilled water.
Rats were assigned to one of four groups: 1 wk DM (DM1; n ϭ 5), 1 wk control (CON1; n ϭ 6), 4 wk DM, (DM4; n ϭ 7), and 4 wk control (CON4; n ϭ 7). DM was induced with streptozotocin (STZ; 60 mg/kg), which was injected into the tail vein immediately after being dissolved in ice-cold sterile saline, while rats were anesthetized, as described previously (50) . Subcutaneous insulin implants (Linplant, LinShin Canada, Scarborough, ON, Canada) were inserted (1/2 implant) at the time of STZ injection to keep blood glucose (BG) at Ϸ20 mM and to allow the rats to maintain their body weight. Rats had free access to 5% sucrose in water for the first 24 h after STZ to guard against hypoglycemia in case STZ was ineffective. Body weight (BW) and BG were measured three times per week in each rat beginning the day before STZ injection until the day they were terminated.
Autoregulation experiment. Briefly, rats were anesthetized with 4% isoflurane (Baxter, Mississauga, ON, Canada) in inspired air (45% O2). Anesthetic concentration was reduced to Ϸ2% during surgery, and then 1.25% thereafter. The trachea was cannulated, and the animal was ventilated by a small animal respirator (TOPO, Kent Scientific, Torrington, CT) operating in timed respiration mode. The ventilator was adjusted to match the breathing rate of the animal, which was Ϸ1 Hz. The left femoral vein was cannulated (PE-50) for infusion of 2% charcoal-washed BSA albumin (Sigma-Aldrich, Oakville, ON, Canada) in saline (1% body wt/h). The left femoral artery was cannulated (PE-90 with narrowed tip) and connected to a pressure transducer driven by a Kent TRN-050 amplifier for measurement of BP. The kidney was exposed by a left subcostal flank incision, freed from surrounding fat, and mounted in a plastic holder. After the renal artery was stripped of fat and nerves, a transit-time ultrasound flow probe (PRB-001, Transonic Systems, Ithaca, NY) was mounted and connected to a flowmeter (TS420; Transonic Systems). The flow probe was secured in place with acoustic coupling gel (NALCO 1181 mixed with surgical lubricant). A motorized aortic occluder was attached to the aorta just superior to the renal artery to facilitate broadband forcing of renal BP. During this time, the kidney was covered with Parafilm.
Drugs were infused directly into the renal artery via a Teflon cannula that was routed from the right femoral artery into the left renal artery. To ensure adequate distribution of drugs within the kidney, a mixing pump was connected to the infusion line, as described previously (41, 47, 48) . Saline vehicle and drugs were infused into the kidney at 3 ml/h. The selective inhibitor of NOS1 [N5-(1-imino-3-butenyl)-L-ornithine, L-VNIO; Cayman Chemical, Ann Arbor, MI] was delivered to achieve 1 M [L-VNIO] in a nominal RBF of 5 ml/min together with L-arginine (2 M; Sigma) to prevent confounding inhibition of NOS3 (48) . The nonselective NOS inhibitor N Gnitro-L-arginine methyl ester (L-NAME; Sigma) was delivered at 1 mg·kg Ϫ1 ·h Ϫ1 for 20 min, and 0.3 mg·kg Ϫ1 ·h Ϫ1 thereafter (41, 47, 48) . During each experimental period, broadband forcing of renal BP was done for 25 min, while BP and RBF were recorded at 500 Hz. Experiments were performed as described previously (47, 48) . The end of surgery was defined as t ϭ 0, so that after a 1-h equilibration period, measurements were begun at t ϭ 60. Each experiment contained four measurement periods: spontaneous BP fluctuations (SPN; t ϭ 60), baseline broadband forcing of BP (BL; t Ϸ 90), L-VNIO (t Ϸ 130) with forcing, and nonselective NOS inhibition (L-NAME; t Ϸ 180) with forcing.
Laser speckle contrast imaging. During each RBF recording period, renal cortical perfusion was monitored using laser speckle contrast imaging (LSCI), as described previously (39, 45, 46) . Briefly, the LSCI camera (FLPI, Moor Instruments, Axminster, UK) was positioned Ϸ18 cm above the surface of the kidney. Surface perfusion was monitored in a field of view Ϸ4 ϫ 5 mm using 113 ϫ 152 pixel frames at 25 Hz. Each frame was spatially filtered (Gaussian, 8 pixel width, ϭ 3.12) and down sampled by a factor of four to produce a series of 27 ϫ 37 pixel images. Twenty-five-Hertz time series of perfusion from each pixel was filtered and down sampled to 2 Hz.
Transfer function analysis. The transfer function between BP and RBF was calculated as previously stated (33, 47, 48) . Briefly, BP and RBF data were low pass filtered to 1 Hz and down sampled to 2 Hz. After subtracting the mean and linearly detrending the data, the power spectra were calculated using Welch's method with 50% overlap, Hamming window, and 512 point vectors. Admittance gain was normalized to renal vascular conductance and presented in decibels as 20 log(Gain). The slope of gain reduction in the myogenic frequency range (0.1-0.3 Hz) was estimated in each record. Myogenic phase peak was estimated as the average phase in the frequency range of myogenic gain reduction. Slope of gain reduction and height of phase peak provide a formal assessment of the input-output relationship between BP and RBF (38) . The mean transfer function gain from 0.3 to 0.5 Hz was calculated to provide information about renal vascular compliance in each rat (15) . Mean transfer function gain from 0.01 to 0.02 Hz was calculated to provide information about the attenuation of low-frequency fluctuations in BP.
LSCI transfer function analysis. Transfer function analysis was performed in the same manner on flux time series extracted from the mean LSCI. This was used to evaluate autoregulation dynamics visible on the surface of the kidney. The Moor FLPI lacks the resolution to assign MR dynamics to individual nephrons, so we treat the field of view as a flow field. Thus transfer function analysis performed on the flux time series from each LSCI pixel provides an MR field. This information was then used to determine the variance in autoregulation parameters on the surface of the kidney. Because of the large number of calculations required (999 per animal per period), we did not manually annotate each transfer function. Instead, we measured the slope of gain over the interval that had the highest correlation with frequency within the range 0.05-0.3 Hz. When a pixel did not have a region of its gain function that satisfied this method, we determined the slope of gain reduction from 0.05 to 0.15 Hz, as previously reported (46) . As with RBF, the phase peak was determined as the mean phase amplitude in the same frequency band.
Transfer function quantification. To test for treatment-dependent differences, we extracted three scalars: Coherence between input (BP) and output (RBF or LSCI) in the frequency range 0.05-0.08 Hz, slope of gain reduction in the myogenic frequency range, and the height of the associated phase peak. A two-step process was used to automatically quantify transfer function data. The first step is to fit the transfer function gain with a sigmoid function of the type:
shown in Eq. 1, where y is the admittance gain and x is frequency. Then the slope of the fitted sigmoid is measured in the linear region of the curve. This is accomplished by measuring between the respective minimum and maximum values of the second derivative of the fitted sigmoid (Fig. 1) . The frequencies at which the linear region begins and ends define the region of gain reduction and phase peak to determine. When a linear region was not identified within predetermined acceptable bounds [slope (Ϫ5, 80) decibels/decade], values for coherence, gain slope, and phase peak for that pixel were set to Not-a-Number (NaN) and excluded from subsequent analysis. The method was tested against the manually calculated gain slopes and phase peaks in the BP-RBF transfer functions from all animals in all conditions. The returned values of gain slope and phase peak correlated significantly with the manual technique, as shown in Fig. 2 .
Immunofluorescence microscopy. After each experiment, the left kidney was perfused with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2HPO4, 2 mM KH2PO4) until effluent was clear of blood, then perfused at 100 mmHg with 3% paraformaldehyde (Sigma) dissolved in PBS for 15 min. The renal capsule was repeatedly perforated with a 23G needle (20) , and the kidney was immersed in freshly made 3% paraformaldehyde in PBS for 3 h. After fixation, each kidney was bisected transversely and immersed in 30% sucrose in PBS at 4°C overnight. Frozen sections were made on a cryostat (Leica Microsystems, Wetzlar, Germany) at 4 m and mounted on Superfrost Plus slides (Thermo Fisher Scientific, Burlington, ON, Canada). Sections were washed in PBS for 15 min, and antigen retrieval was performed by incubating the sections in sodium citrate (pH 6) for 20 min at 95°C. Sections were blocked in 10% normal goat serum in PBS (Sigma Aldrich). Each section was counterstained with periodic acid Schiff (PAS; Sigma Aldrich), according to the manufacturer's instructions. The sections were incubated with a mouse monoclonal antibody against NOS1 (625 ng/ml, BD Biosciences cat. no. 610308) at room temperature for 60 min. The anti-NOS1 antibody was detected by incubating the sections with goat anti-mouse IgG conjugated to Alexa Fluor 488 (1.25 g/ml; Life Technologies, Burlington, ON, Canada) at room temperature for 60 min. Sections were mounted in antifade reagent mixed with the nuclear stain 4=,6-diamidino-2-phenylindole (DAPI; ProLong Gold ϩ DAPI, Life Technologies). Images were acquired with an epifluorescence microscope (Leica Microsystems). DAPI was imaged at 470 nm, NOS1 was imaged at 530 nm, and PAS was imaged at 645 nm.
Statistical analysis. Data were collected and analyzed using MatLab (R2014b; The Mathworks, Natick, MA). Results were analyzed as fractional changes with respect to the previous experimental period, i.e., L-VNIO compared with BL, and L-NAME compared with L-VNIO. These differences were compared using two-way ANOVA with the drug infusions as repeated measures and the animal group as an independent factor. Planned contrasts were used (CON1 vs. DM1, CON4 vs. DM4, and DM1 vs. DM4) for group comparisons. Statistical calculations were performed in SPSS v22 (IBM, Armonk, NY). Data are shown as means Ϯ SE, and P Ͻ 0.05 was considered statistically significant.
RESULTS
Diabetes.
Mean BW and BG in each group of rats are shown in Fig. 3 . BW and the ratio of BW to body length were not significantly different between DM and CON rats (Table 1) . BW declined in both DM groups, although not significantly, for the first 4 -5 days and then stabilized, while CON rats maintained a stable BW (Fig. 3) . BG levels were normal for the entire study period in CON rats, while STZ caused significant hyperglycemia in DM rats that was held at Ϸ20 mM with subcutaneous insulin implants (Fig. 3) . High BG combined with slight BW loss but similar weight-to-length ratios, was consistent with successful induction of DM with maintenance of metabolism (33, 51) .
Hemodynamics. Mean BP and RBF during the terminal procedure are shown in Table 2 . Spontaneous BP, RBF, and renal vascular conductance were not significantly different among the four groups of rats (Table 2) . BP was not different among the groups or experimental periods because BP was forced at similar pressures to facilitate comparison between RBF dynamics. RBF and renal vascular conductance were reduced by infusion of L-NAME, but not L-VNIO, in all groups (Table 2 ). Laser speckle conductance was higher in CON4 than DM4, during BL. L-VNIO did not significantly change LSCI conductance, while L-NAME reduced it equivalently in all groups.
RBF autoregulation dynamics. RBF autoregulation dynamics for CON1 and DM1 groups are shown in Fig. 4 . By design, Manual phase peak (rad) Automatic phase peak (rad) Fig. 2 . Correlation between manually-annotated and automatically detected gain slope (top) and phase peak (bottom) (n ϭ 75 observations from 25 animals). The hand annotation of gain and phase parameters was performed first, to minimize bias from the automatic results. Automatic quantification of gain slope and phase peak was significantly correlated with manual quantification (P Ͻ 10 Ϫ33 ) in both cases.
both groups had similar BP power during BL, L-VNIO, and L-NAME periods. Coherence was Ͼ0.5 across most of the frequency spectrum, lending confidence to transfer function interpretation. CON1 gain declined in the frequency range from Ϸ0.15 Hz to 0.05 Hz, paired with a peak in the admittance phase in the same frequency range, consistent with functional myogenic autoregulation. There were no significant effects of L-VNIO or L-NAME on these variables (Table 3) . DM1 rats showed coherence Ͼ0.5 similar to CON1, but the transfer function is not consistent with effective autoregulation. Gain reduction was significantly attenuated, while the phase peak was significantly smaller than CON1. Infusion of L-VNIO and L-NAME did not significantly improve autoregulation in DM1 rats.
The CON4 group showed results similar to CON1 (Fig. 5) , where the signature of effective autoregulation was present, although there were no significant effects of L-VNIO or L-NAME. In contrast to DM1, the DM4 group showed signs of effective autoregulation. There was a characteristic reduction in gain, and a coincident rise in phase. L-VNIO and L-NAME infusion did not affect gain reduction or phase peaks in CON4. L-NAME did not increase admittance gain in the frequency range (0.3-0.5 Hz) in DM4 rats.
Secondary analysis of the low frequency region showed mean transfer function gain in the frequency range (0.01-0.02 Hz) was significantly more positive in the DM1 rats than in CON1 (Ϫ7.2 Ϯ 1.5 vs. Ϫ4.5 Ϯ 1.7, P ϭ 0.039). Similarly, low-frequency gain was significantly more positive in DM4 than in CON4 (Ϫ7.9 Ϯ 1.4 vs. Ϫ4.6 Ϯ 1.4, P ϭ 0.001).
LSCI autoregulation dynamics. LSCI dynamics were measured on the basis of the mean of the entire field of view, which we term the mean cortical perfusion signal, and separately, on the perfusion signals that arise from each individual pixel in the field of view of the LSCI.
Mean cortical perfusion signal. LSCI dynamics showed similar results to RBF dynamics, except there was a steeper decline in coherence below 0.08 Hz, which was expected because of the inherently lower signal-to-noise ratio in LSCI than RBF. The transfer functions showed the characteristic signatures of autoregulation in CON1, and confirmed impairment of autoregulation in DM1 (Fig. 6) . CON4 also showed the characteristics of effective autoregulation, whereas DM4 did not (Fig. 7) . The slope of gain reduction was significantly lower in DM4 rats than in CON4 (Table 4) .
Surface autoregulation dynamics. The transfer function from each LSCI pixel on the surface of the kidney was quantified by measuring the slope of gain reduction and height of the associated phase peak (Table 4) . In all groups, there was considerable spatial heterogeneity of the efficacy of autoregulation. An example from each group, during the BL period, is shown in Fig. 8 . Note that NaN pixels, which are gray, are rare in CON1, CON4, and DM4, but are common in DM1. Thus not only the parameters (Table 4) , but also the existence of MR itself shows increased spatial heterogeneity in DM1. During BL, DM1 rats had greater coefficient of variation (CV) in gain slope and phase peak during BL, and reduced CV in coherence from 0.05 to 0.08 Hz, while DM4 rats showed increased gain slope but no significant change in phase peak CV. L-VNIO and L-NAME had no significant effects on the CV of any transfer function parameters on the renal surface.
Immunofluorescence. We assessed NOS1 expression in Ϸ12,000 glomeruli (240 glomeruli per section, 2 sections per animal, 25 animals) and found consistent expression of NOS1 in macula densa cells, but did not find expression in efferent arterioles. NOS1 protein expression in each group of rats was similar in its distribution in the kidney. In all animals, expression of NOS1 was only present in macula densa cells (Fig. 9) , despite the lack of vascular response to L-VNIO. The proportion of positively labeled macula densa cells to the total number of visible distal tubules was similar in all groups (Table 5) . Examination of the tissue using PAS fluorescence revealed an absence of overt tissue damage.
DISCUSSION
The main result of this study is that dynamic autoregulation of RBF begins to recover in established DM after being significantly impaired in early DM. Previously, Bell et al. (5) reported that chronic NOS inhibition prevented early DMassociated increases in RBF and impairment of autoregulation. Others have reported impaired autoregulation in early DM (5, 6) and during acute hyperglycemia (68) . In apparent contrast, we and others reported normal or slightly improved autoregulation in established DM (33, 37, 50, 57) . We hypothesized that these seemingly opposite reports could be explained by transient impairment of autoregulation in early DM, with recovery of autoregulation later. Therefore, we proposed that detrimental changes in autoregulation that occur in early DM are caused by increased physiological influence of NO. Of the three NOS Blood glucose (mM) Time (days) Fig. 3 . Mean body weight (top) and blood glucose (bottom) in each group of rats. Body weight in the diabetic rats (gray) declined slightly during the first 4 or 5 days of the study period, while the body weight in control rats was relatively constant (black). There were no significant differences in blood glucose or body weight between 1 wk (dashed) and 4 wk (solid) groups. isoforms expressed in the kidney (1, 62) , the specific isoforms that are involved in modulating renal function in DM remain unclear.
The results show reduced effectiveness of MR in early DM with a suggestion from gain at 0.01-0.02 Hz of reduced overall autoregulatory effectiveness. After 4 wk DM, the MR, assessed by gain slope and amplitude of the associated phase peak (38) , is not different from CON4 in the RBF signal and only slightly different in the LSCI signal. We interpret this to show initial impairment and subsequent recovery of MR. The contribution of TGF to dynamic autoregulation is more difficult to assess with these data. Only in DM1 can one conclude that gain reduction by MR and TGF was impaired. While gain at 0.01-0.02 Hz was higher (less attenuation) in DM1 and DM4 than in CON1 and CON4, respectively, coherence in this region of the spectrum was marginal for CON1, CON4, and DM4, making quantitative interpretation somewhat problematic for all groups except DM1.
We tested the role of NOS1-derived NO because it has been previously reported to modulate TGF responses (24) and to transduce information between TGF and the myogenic response (48) . Furthermore, NOS1-dependent modulation of ); CPS, laser speckle cortical perfusion signal (AU); GCPS, nominal CPS conductance (AU/mmHg). *P Ͻ 0. 05 compared to previous record. †P Ͻ 0.05 compared to respective CON group. Fig. 4 . Transfer function analysis of 1 wk groups. Means (solid) Ϯ SE (dashed) are shown for each recording. Blood pressure power was similar between both control 1 (CON1) and diabetes mellitus 1 (DM1), and across each recording period, suggesting the transfer functions had the same inputs, so their outputs were appropriate to compare. Coherence was Ͼ0.5 in all recordings, suggesting the RBF-BP relationship was sufficiently linear for transfer function analysis. Gain and phase showed the signatures of autoregulation in CON1 rats, while these signatures were not observed in DM1. Baseline is shown in black, L-VNIO in red, and L-NAME in blue. Data are presented as means Ϯ SE. Coh0.05-0.08, coherence from 0.05-0.08 Hz; Gain slope (decibels/decade) and phase peak (radians) are generated by the myogenic mechanism. Gain0.3-0.5 is the gain in the pressure-passive region of the spectrum (0.3-0.5 Hz). †P Ͻ 0.05 compared to respective CON group.
TGF has been reported to be absent in early DM (54) . For these reasons and because of the exclusive expression of NOS1 in macula densa cells, we hypothesized that NOS1 was a likely contributor to NO derangements in DM. However, others have reported that NOS3 is the most important source of NO involved with modulating myogenic autoregulation (17) . We selectively inhibited NOS1 and then tested the role of NOS3 by subsequently inhibiting all NOS with L-NAME. Because NOS2 has not been reported to play a vascular role in rats other than the Brown Norway strain (63), results of nonselective NOS inhibition after previous NOS1 inhibition indicate the contribution of NOS3.
Interestingly, inhibition of NOS1, and of all NOS, had no significant effects on dynamic autoregulation in this study. The significant reduction in RBF caused by L-NAME means that there was NO in the kidney that exerted a tonic vasodilator influence on the renal vasculature. These results are in contrast to those of Bell et al. (5), but consistent with Lau et al. (33) . Previously, the lack of effect of L-NAME on autoregulation in Long-Evans rats (33) and spontaneously hypertensive rats (64) was thought to be because autoregulation was already operating as a second-order system, and no further improvement was possible. If that were true, L-NAME would have had no effect on CON1 or CON4 rats, but it would have improved autoregulation in the DM1 rats. As there was no effect of L-NAME, even when autoregulation was impaired, this indicates that autoregulation in the Long-Evans rats used in this study was not significantly modulated by NO. Although L-NAME caused entirely normal reductions in vascular conductance (Ն50% reduction) (43, 47, 48, 64, 66) , there was little effect of NO on autoregulation. We do not have a good explanation for the lack of sensitivity of the MR to NOS inhibition in this study. Nevertheless, our data continue to support DM-induced impairment of autoregulation.
Our results are not consistent with a role for NO in the DM-induced impairment of autoregulation; however, hyperglycemia itself may be responsible. Acute hyperglycemia has been reported to impair renal autoregulation (68) , as well as myogenic responses in a variety of vascular beds (7, 13, 14, 22, 27) . These reports combined with our data suggest that early hyperglycemia may have impaired myogenic autoregulation. However, the kidney has been shown to adapt to some perturbations caused by DM. The beneficial effects of acute sodiumglucose transport inhibition on the diabetic kidney are not observed chronically (55) , and plasma renin activity has been reported to be elevated in rats after 1 wk DM, but to return to normal after 2 wk (19), for example. These reports suggest that although there are early responses of the kidney to hyperglycemia at the onset of DM, there is some adaptation over time. The observation that autoregulation was improved after 4 wk DM compared with 1 wk DM is consistent with a timedependent effect of DM on autoregulation, and suggests the kidneys were in the process of adapting to hyperglycemia.
Previously, we, and others, reported that autoregulation dynamics are synchronized on the surface of the kidney (9, 23, 39, 45) . Simulation studies suggest that networks of arterioles would provide smoothing of blood flow in space and time (18, 58) , which suggests synchronization may contribute to the efficacy of autoregulation. It is likely that synchronization is mediated by electrotonic conduction of electrical signals via endothelial gap junctions (35, 39, 53) . In DM, the distribution of renal arteriolar gap junctions is abnormal, with an accentuated difference in the preglomerular and postglomerular arterioles (71) . Autoregulation in Type 2 DM has also been reported to be impaired and is associated with reduced gap junction communication in DM (53) . Therefore, we planned to test the effect of DM on the spatial heterogeneity of autoregulation by monitoring surface perfusion with LSCI. We predicted that if DM reduces gap junction communication in the kidney, as described by Takenaka et al. (53) , there will be reduced synchronization of autoregulation, resulting in increased spatial heterogeneity of autoregulation that is less effective overall.
There was considerable heterogeneity of autoregulation variables, including gain slope and phase peak, across the surface of CON1 and CON4 rats. When measured as CV, there was increased spatial heterogeneity in DM1 rats but not DM4. However, because of the lack of autoregulation in DM1 (i.e., substantial increase in number of NaN pixels), we were not able to directly measure synchronization of autoregulation dynamics. A NaN pixel is, of course, one in which the MR is so weak as to be indistinguishable from noise. Thus, while it is slope of admittance gain reduction in the myogenic frequency range. Bottom: phase peak in the same frequency range as myogenic gain reduction. Pixels whose gain slopes were outside the acceptable interval (Ϫ5, 80) decibels/decade were set to NaN and are shown in gray. Effectively, they show absence of myogenic autoregulation in occasional pixels (CON1, CON4, DM4) or over large areas of the field (DM1).
not possible to conclude that there was reduced regional synchronization in the experiment, these results are consistent with our previous report that surface autoregulation is heterogeneous (46) . They indicate that some areas of the kidney retain efficient autoregulation, while others do not, and that this scenario is exacerbated in early DM. Overall, the results of this study are consistent with previous reports in the literature regarding the effectiveness of autoregulation in early (5, 6) and established DM (33, 50) . However, we could not establish a role for NO in early DM. Although Bell et al. (5) reported improved autoregulation in early DM in the presence of L-NAME, they measured autoregulation while the rats had significantly increased BP compared with their respective controls. It has been previously reported that increased BP can increase the operating frequency of MR (65) . Furthermore, our study was performed on anesthetized rats, which results in lower BP power than would be observed in conscious rats used by Bell et al. (5, 6) . How these differences might contribute to disparate findings with respect to a role for NO is not presently clear.
Because our previous results suggested spatial coordination of autoregulation is important to its effectiveness (39, 45) , we probed the extent of spatial heterogeneity of autoregulation. We found that increased heterogeneity of MR dynamics appears in conjunction with impaired autoregulation. This is the first observation of increased spatial heterogeneity of perfusion dynamics in early DM, and suggests that loss of spatial smoothing (increased heterogeneity) may contribute to the autoregulatory impairment seen in early DM.
Perspectives and Significance
This study demonstrated that transient impairment of autoregulation is possible in early STZ-induced DM. We have shown that spatial heterogeneity is increased in early DM and have suggested that this may cause impaired autoregulation. The quantification of autoregulation by means of an automatic method allowed us to measure autoregulation locally and systematically on the renal surface. This provides a richer picture of autoregulation dynamics than reported previously. Furthermore, application of these methods raises the possibility of quantifying autoregulation obtained from a time-varying transfer function (12, 40, 48, 72) , to determine changes in autoregulation that occur over time. The illustration of spatial heterogeneity of autoregulation and the effect of DM on this heterogeneity make the role of inter-nephron communication an interesting target in the study of autoregulation. Data are presented as means Ϯ SE. The number of NOS1-positive macula densas was counted as a proportion of the total visible distal tubule sections in each section. DCT, distal convoluted tubules; NOS1, nitric oxide synthase 1; MD, macula densa; NOS1ϩMD, NOS1-positive MD.
